Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1824 News Items found New Targeted Therapy, Ulixertinib, Shows Promise for Histiocytosis, a Rare Blood Cancer Thursday, October 23, 2025 Learn how MSK research on a family of rare blood cancers called histiocytosis is leading to new targeted therapies that benefit patients. ESMO 2025: MSK Presents New Research, Including Latest on Lung and Pancreatic Cancer Treatments Tuesday, October 21, 2025 MSK highlights from the recent European Society for Medical Oncology (ESMO) Congress include promising findings on new lung, pancreatic, and colorectal cancer treatments and new insights for how molecular testing can guide personalized medicine. Article Latest Research Into Overcoming Resistance to Breast Cancer Targeted Therapies Thursday, October 16, 2025 Learn how MSK's researchers are making important strides in overcoming breast cancer resistance. The Future of Immunotherapy Research at MSK: A Conversation With Dr. Andy Minn, Chair of MSK’s New Immuno-Oncology Program Wednesday, October 15, 2025 Dr. Andy Minn, the inaugural chair of MSK's Immuno-Oncology Program, discusses his vision for the program and what it means for patients. How Routine Prenatal Tests Can Detect Cancer and What It Means for Pregnant Women Monday, October 6, 2025 Learn how noninvasive prenatal tests designed to screen for genetic abnormalities in the fetus may detect the presence of cancer in pregnant women. In the Lab New Research Helps Model How the Immune System Shapes Cancer Development Monday, October 6, 2025 Read about MSK research that sheds light on how the innate immune system interacts with developing cancer cells. What Is Invasive Lobular Carcinoma? MSK Doctors Explain Thursday, October 2, 2025 Learn about how MSK’s new Lobular Breast Cancer Program is working to improve outcomes for people with invasive lobular breast cancer and other types of LBC. ASTRO 2025 Highlights From MSK Wednesday, October 1, 2025 Learn about some of the exciting research that MSK doctors and scientists presented at the 2025 Annual Meeting of the American Society for Radiation Oncology. Immunologist Chrysothemis Brown Named a 2025 Howard Hughes Medical Institute Freeman Hrabowski Scholar Wednesday, October 1, 2025 Dr. Brown, whose research has been shedding light on the development of the early life immune system and its relationship to autoimmunity, allergy, inflammation and cancer, was among 30 early career scientists nationwide selected for the 2025 class of scholars. Clinical Update Pembrolizumab for Locally Advanced Head and Neck Squamous Cell Carcinoma Approved by the FDA for Use Before and After Surgery Wednesday, October 1, 2025 Read about an FDA approval for immunotherapy to treat head and neck squamous cell carcinoma. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment